000 | 01167 a2200301 4500 | ||
---|---|---|---|
005 | 20250517151300.0 | ||
264 | 0 | _c20181112 | |
008 | 201811s 0 0 eng d | ||
022 | _a1523-6838 | ||
024 | 7 |
_a10.1053/j.ajkd.2017.02.368 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJun, Min | |
245 | 0 | 0 |
_aIn Reply to 'International Normalized Ratio Control in Patients With Atrial Fibrillation and CKD'. _h[electronic resource] |
260 |
_bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _c06 2017 |
||
300 |
_a863-864 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aAnticoagulants |
650 | 0 | 4 | _aAtrial Fibrillation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInternational Normalized Ratio |
650 | 0 | 4 | _aRenal Insufficiency, Chronic |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aStroke |
650 | 0 | 4 | _aWarfarin |
700 | 1 | _aHemmelgarn, Brenda R | |
773 | 0 |
_tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _gvol. 69 _gno. 6 _gp. 863-864 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.ajkd.2017.02.368 _zAvailable from publisher's website |
999 |
_c27098634 _d27098634 |